Randox Lipoprotein(a) Reagents

Randox Laboratories offers a specialised range of Lipoprotein(a) reagents designed to support accurate and reliable cardiovascular risk assessment in clinical laboratories. Developed for the quantitative determination of Lp(a) in serum or plasma, the assay helps healthcare professionals identify inherited cardiovascular risk factors that may not be detected through routine lipid testing alone.

The Randox Lp(a) assay is standardised to the WHO/IFCC reference material and calibrated in nmol/L, helping to minimise size-related bias associated with apo(a) isoform variability and providing a more accurate reflection of cardiovascular risk. Designed for use on a wide range of clinical chemistry analysers, the reagent is supplied in a convenient liquid ready-to-use format to simplify laboratory workflow and improve operational efficiency.

To support reliable and consistent performance, Randox also provides dedicated Lp(a) calibrators and quality controls, enabling laboratories to maintain confidence in assay accuracy and quality assurance processes. With excellent correlation, precision and broad instrument compatibility, Randox Lp(a) reagents deliver a dependable solution for modern cardiovascular diagnostics and risk assessment.